These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1561800)

  • 21. Elective lymph node dissection for clinical stage I malignant melanoma.
    Evans RA
    J Surg Oncol; 1994 Sep; 57(1):31-2. PubMed ID: 8065150
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preventive lymphadenectomy in cutaneous malignant melanomas. A matched pair study].
    Hotz G; Hagedorn M; Petres J; Wiebelt H
    Hautarzt; 1986 Oct; 37(10):554-9. PubMed ID: 3793478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of elective lymph node excision in melanoma of the trunk].
    Zimmermann T; Buhr J; Kelm C; Padberg W
    Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elective lymph node dissection in stage I melanoma--necessary or not?
    Adams CM; Giltman LI
    Am Surg; 1985 Sep; 51(9):504-7. PubMed ID: 3898948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
    Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
    Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
    McCarthy WH; Shaw HM; Milton GW
    Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biostatistical basis of elective node dissection for malignant melanoma.
    Fortner JG; Woodruff J; Schottenfeld D; Maclean B
    Ann Surg; 1977 Jul; 186(1):101-3. PubMed ID: 879870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
    Essner R
    Expert Rev Anticancer Ther; 2010 May; 10(5):723-8. PubMed ID: 20470004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete lymph node dissection for regional nodal metastasis.
    Dzwierzynski WW
    Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials.
    Lens MB; Dawes M; Goodacre T; Newton-Bishop JA
    Arch Surg; 2002 Apr; 137(4):458-61. PubMed ID: 11926952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous malignant melanoma: current views on pathogenesis, diagnosis, and surgical management.
    Adam YG; Efron G
    Surgery; 1983 Apr; 93(4):481-94. PubMed ID: 6340230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical therapy of malignant melanoma of the skin].
    Bachter D
    Praxis (Bern 1994); 2001 Feb; 90(8):307-13. PubMed ID: 11256333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
    Kjaer BK; Knudsen MA; Dahlstrøm KK
    Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elective lymph node dissection for malignant melanoma: the tumor burden of nodal disease.
    Evans RA
    Anticancer Res; 1995; 15(2):575-9. PubMed ID: 7763040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of surgery in the treatment of cutaneous melanoma].
    Guggenheim M; Dummer R; Giovanoli P
    Praxis (Bern 1994); 2011 Jul; 100(15):911-6. PubMed ID: 21792806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from the Sunbelt Melanoma Trial.
    McMasters KM; Noyes RD; Reintgen DS; Goydos JS; Beitsch PD; Davidson BS; Sussman JJ; Gershenwald JE; Ross MI;
    J Surg Oncol; 2004 Jul; 86(4):212-23. PubMed ID: 15221928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
    van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
    Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.